Tango Therapeutics, Inc. (TNGX) Capital expenditures 2020–2025
Tango Therapeutics, Inc. (TNGX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.0MFY2025 · since FY2020: $1.1M → $1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.0M | +39.0% |
| FY2024 | $754,000 | -50.6% |
| FY2023 | $1.5M | -80.2% |
| FY2022 | $7.7M | +318.7% |
| FY2021 | $1.8M | +66.1% |
| FY2020 | $1.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice